Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
Published: December 12th 2022 | Updated: October 1st 2024
When to Stop or Switch JAK Inhibitor Therapy in Myelofibrosis
Published: January 6th 2023 | Updated: October 1st 2024
Bridging Options for CAR T-Cell Therapy in R/R DLBCL
Published: September 28th 2024 | Updated: October 1st 2024
Encouraging Efficacy and Safety Profile Demonstrated by Anito-Cel in R/R Multiple Myeloma
Published: September 29th 2024 | Updated: October 1st 2024
The Targeted Pulse: NKT2152 Sparks Excitement in RCC, Amivantamab/Chemotherapy Combo Receives Approval for EGFR-Mutant NSCLC, and More
Published: July 24th 2024 | Updated: October 1st 2024
Peers Discuss Sacituzumab Govitecan in HR+ mBC Post Endocrine Therapy